{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/28/3302971/0/en/Akari-Therapeutics-Discusses-Breakthrough-Potential-of-AKTX-101-and-Novel-Spliceosome-Modulating-ADC-Platform-in-Virtual-Investor-What-This-Means-Segment-Following-ASCO-Abstract-Ac.html", "message": "News view counter 763718 successfully enlarged"}